Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Record History now includes a new revision entry for v3.5.4 and removes the previous v3.5.3 entry, updating the page's release notes to reflect the latest versioning of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:43:42.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, indicating a backend/site release rather than a modification to the clinical trial’s record history or study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added Study Design and Study Status entries in the latest history versions; a previous entry dated 2026-03-05 was removed.
    Difference
    0.5%
    Check dated 2026-04-02T15:23:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:58:36.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a new Study Status entry to the record history and updated the record to revision v3.4.3 on 2026-03-05.
    Difference
    0.5%
    Check dated 2026-03-12T00:38:19.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.